NCT04728035 2024-07-26Study of Irinotecan Liposome Injection in Patients With Advanced Breast CanceCSPC Ouyi Pharmaceutical Co., Ltd.Phase 1 Completed119 enrolled
NCT01770353 2019-11-27MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentIpsenPhase 1 Completed45 enrolled 33 charts